BridgeBio Pharma said on Monday its experimental drug for a rare muscle disorder, which currently has no approved treatments, showed improvements in motor and lung function in a late-stage trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback